Comment on

• Double-blind randomised controlled trial of monoclonal antibody to human tumour necrosis factor in treatment of septic shock. NORASEPT II Study Group.

  Abraham E, Anzueto A, Gutierrez G, Tessler S, San Pedro G, Wunderink R, Dal Nogare A, Nasraway S, Berman S, Cooney R, Levy H, Baughman R, Rumbak M, Light RB, Poole L, Allred R, Constant J, Pennington J, Porter S. Abraham E, et al. Lancet. 1998 Mar 28;351(9107):929-33. Lancet. 1998. PMID: 9734938 Clinical Trial.
• Anti-inflammatory cytokine profile and mortality in febrile patients.

  van Dissel JT, van Langevelde P, Westendorp RG, Kwappenberg K, Frölich M. van Dissel JT, et al. Lancet. 1998 Mar 28;351(9107):950-3. doi: 10.1016/S0140-6736(05)60606-X. Lancet. 1998. PMID: 9734942